HEALTH-P2 Intervention for Preventing Obesity During and After Pregnancy

(HEALTH-P2 Trial)

Not currently recruiting at 1 trial location
RT
CS
Overseen ByCindy Schwarz, MPH,MS,RD
Age: 18+
Sex: Any
Trial Phase: Phase 2
Sponsor: Washington University School of Medicine
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine if the HEALTH-P2 program (Healthy Weight Across Pregnancy and Postpartum Period Intervention) can prevent excessive weight gain during and after pregnancy. It evaluates the program's effectiveness in real-world settings, particularly through the Parents as Teachers group. The trial also assesses the training effectiveness for program facilitators and its potential impact on long-term health issues like heart disease and diabetes. This trial targets pregnant women who were overweight or obese before pregnancy and are involved in or willing to join Parents as Teachers until their baby turns one. Participants should also be able to join a walking program. As a Phase 2 trial, this research focuses on measuring the treatment's effectiveness in an initial, smaller group of people.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research shows that HEALTH-P2, a program designed to prevent excessive weight gain before and after pregnancy, has been tested for safety and effectiveness. Studies on similar programs for pregnant women suggest they are generally safe and well-received, with most participants not experiencing harmful effects.

This trial is in phase two, indicating that the program has already passed initial safety checks. This phase focuses more on the program's effectiveness while still monitoring safety. Serious safety issues in earlier phases would have prevented the program from advancing.

In summary, based on current knowledge, HEALTH-P2 appears safe for participants, with no major safety concerns reported in similar past studies. Participants should consult their healthcare provider if they have specific concerns or conditions.12345

Why are researchers excited about this trial?

Researchers are excited about the HEALTH-P2 intervention because it introduces a proactive, educational approach to preventing obesity during and after pregnancy. Unlike standard care, which typically focuses on postpartum weight management or diet and exercise programs, HEALTH-P2 leverages trained parent educators to deliver a specialized curriculum. This method aims to equip expectant and new mothers with practical strategies and support tailored to their unique needs, potentially leading to healthier outcomes for both mothers and their children. By integrating education into routine care, this intervention could set a new standard for comprehensive prenatal and postnatal health.

What evidence suggests that the HEALTH-P2 intervention is effective for preventing obesity during and after pregnancy?

Research shows that the HEALTH-P2 program, which participants in this trial may receive, aims to prevent excessive weight gain during pregnancy and up to a year after childbirth. Studies on similar programs have found they can help manage weight gain during these critical periods. Early results suggest that focusing on weight management for new and expecting mothers can reduce the risk of obesity and related health issues like heart disease and diabetes. Although results have been modest, combining education and support appears promising for long-term weight control. Designed for everyday use, this program could be more accessible and beneficial for many families. Participants in the trial will receive either the HEALTH-P2 program or usual care, providing a comparison to evaluate the program's effectiveness.12346

Who Is on the Research Team?

RG

Rachel G Tabak, PhD, RD

Principal Investigator

Washington University School of Medicine

DH

Debra Haire-Joshu, PhD

Principal Investigator

Washington University School of Medicine

Are You a Good Fit for This Trial?

This trial is for pregnant women aged 18-45 who are overweight or obese, speak English or Spanish, and are willing to participate in a program called Parents as Teachers (PAT) until their baby turns one. They must not plan another pregnancy before their current baby's first birthday and should be able to engage in walking.

Inclusion Criteria

Deliver PAT at a site participating in the study
overweight or obese (BMI over 25 kg/m2) before becoming pregnant
participating or willing to participate in PAT at a participating PAT site until baby turns 1
See 3 more

Exclusion Criteria

I cannot participate in a walking program.
planning to become pregnant again before their baby turns 1

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive the HEALTH-P2 intervention through trained parent educators as part of routine practice

12 months
Regular visits as part of routine practice

Follow-up

Participants are monitored for weight change and other health outcomes postpartum

12 months

Implementation Evaluation

Evaluation of implementation outcomes such as fidelity, acceptability, and feasibility

2-4 years

What Are the Treatments Tested in This Trial?

Interventions

  • HEALTH-P2
  • Usual Care
Trial Overview The study tests the HEALTH-P2 intervention aimed at preventing excessive weight gain during pregnancy through the first year postpartum. It compares this with usual care and assesses how well it works when applied by PAT, focusing on outcomes like obesity prevention and chronic disease impact.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: HEALTH-P2Experimental Treatment1 Intervention
Group II: Usual CareActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Washington University School of Medicine

Lead Sponsor

Trials
2,027
Recruited
2,353,000+

Published Research Related to This Trial

The mums OnLiNE intervention, which included an online calorie tracking program and dietitian support, led to a significant reduction in waist circumference among first-time mothers, decreasing by 6.4 cm compared to control groups.
While the intervention showed promise in waist circumference reduction, it did not result in significant changes in postpartum weight retention, diet, physical activity, or sedentary behavior, indicating the need for further research on effective strategies for weight management in postpartum women.
A pilot intervention to reduce postpartum weight retention and central adiposity in first-time mothers: results from the mums OnLiNE (Online, Lifestyle, Nutrition & Exercise) study.van der Pligt, P., Ball, K., Hesketh, KD., et al.[2019]
A case study of a 32-year-old woman who gained excess weight during pregnancy showed that a 6-month personalized health planning with integrative health coaching (PHP-IHC) intervention improved her physical activity, energy expenditure, and confidence in health-promoting behaviors.
Although she did not reach her target weight by the end of the coaching sessions, follow-up 8 months later revealed she achieved her goal, suggesting that PHP-IHC can effectively support postpartum weight management.
Personalized health planning with integrative health coaching to reduce obesity risk among women gaining excess weight during pregnancy.Yang, NY., Wroth, S., Parham, C., et al.[2022]
The IMPACT DIABETES Bump2Baby study is testing a mobile health (mHealth) coaching intervention called Bump2Baby and Me (B2B&Me) for women at risk of gestational diabetes, aiming to improve health behaviors during pregnancy and postpartum through personalized coaching and support.
This multicenter randomized controlled trial will involve 800 women across four countries and is designed to evaluate both the feasibility and effectiveness of the intervention, with results expected in 2024, marking it as the first hybrid effectiveness-implementation study of its kind in this area.
A Complex mHealth Coaching Intervention to Prevent Overweight, Obesity, and Diabetes in High-Risk Women in Antenatal Care: Protocol for a Hybrid Type 2 Effectiveness-Implementation Study.O'Reilly, SL., Laws, R., Maindal, HT., et al.[2023]

Citations

Promoting Healthy Weight Across the Pregnancy and ...This project evaluates the effectiveness of an evidence-based intervention (HEALTH-P2) to prevent excessive weight gain from pregnancy through 12 months ...
HEALTH-P2 Intervention for Preventing Obesity During and ...This project evaluates the effectiveness of an evidence-based intervention (HEALTH-P2) to prevent excessive weight gain from pregnancy through 12 months ...
Promoting Healthy Weight Across the Pregnancy and ...This project evaluates the effectiveness of an evidence-based intervention (HEALTH-P2) to prevent excessive weight gain from pregnancy ...
Health In Pregnancy and Postpartum (HIPP) - PMCInterventions to prevent excessive gestational weight gain and promote postpartum weight loss have yielded modest results, particularly in overweight and ...
Mothers' experiences of a lifestyle intervention for weight ...The primary outcome was weight loss 12 months postnatally compared with mothers receiving standard maternity care. Qualitative results are presented from end of ...
Lifestyle Interventions in Overweight and Obese Pregnant or ...This review suggests that successful postpartum weight management is achievable with intensive lifestyle interventions starting in the postpartum period.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security